REFERENCES

1.ACS. Ameican Cancer Society. How is acute lymphocytic leukemia classified? Available at: http://www.cancer.org/cancer/leukemia-acutelymphocyticallinadults/detailedguide/leukemia-acute-lymphocytic-classified. Last updated 2/7/2014f. Accessed 7/21/2014.
2.ACS. American Cancer Society online. How is chronic lymphocytic leukemia staged? Available at: http://www.cancer.org/cancer/leukemia-chroniclymphocyticcll/detailedguide/leukemia-chronic-lymphocytic-staging. Last updated 4/18/2014a. Accessed 7/21/2014.
3.ACS. American Cancer Society online. How is chronic lymphocytic leukemia diagnosed? Available at: http://www.cancer.org/cancer/leukemia-chroniclymphocyticcll/detailedguide/leukemia-chronic-lymphocytic-diagnosis. Last updated 4/18/2014c. Accessed 7/21/2014.
4.ACS. American Cancer Society online. How is chronic myeloid leukemia classified? Available at: http://www.cancer.org/cancer/leukemia-chronicmyeloidcml/detailedguide/leukemia-chronic-myeloid-myelogenous-staging. Last updated 2/10/2014d. Accessed 7/21/2014.
5.ACS. American Cancer Society online. Surgery for chronic myeloid leukemia. Available at: http://www.cancer.org/cancer/leukemia-chronicmyeloidcml/detailedguide/leukemia-chronic-myeloid-myelogenous-treating-surgery. Last updated 2/10/2014b. Accessed 7/21/2014.
6.ACS. American Cancer Society online. Types of stem cell transplants for treating cancer. Available at: http://www.cancer.org/treatment/treatmentsandsideeffects/treatmenttypes/bonemarrowandperipheralbloodstemcelltransplant/stem-cell-transplant-types-of-transplant. Last updated 10/2/2013c. Accessed 7/21/2014.
7.ACS. American Cancer Society. Benzene. Available at: http://www.cancer.org/cancer/cancercauses/othercarcinogens/intheworkplace/benzene. Last updated 12/9/2013b. Accessed 8/18/2014.
8.ACS. American Cancer Society. Find Support and Treatment page. Staging. Available at: http://www.cancer.org/treatment/understandingyourdiagnosis/staging. Last updated 6/7/2012. Accessed 7/21/2014.
9.ACS. American Cancer Society. How is acute myeloid leukemia classified? Available at: http://www.cancer.org/cancer/leukemia-acutemyeloidaml/detailedguide/leukemia-acute-myeloid-myelogenous-classified. Last updated 2/7/2014e. Accessed 7/21/2014.
10.ACS. American Cancer Society. Leukemia-Acute Lymphocytic Overview. Survival rates for acute lymphocytic leukemia. http://www.cancer.org/cancer/leukemia-acutelymphocyticallinadults/overviewguide/leukemia-all-overview-survival-rates. Last updated 6/25/2013d. Accessed 8/19/2014.
11.ACS. American Cancer Society. Targeted Therapies for Chronic Myeloid Leukemia. Available at http://www.cancer.org/cancer/leukemia-chronicmyeloidcml/detailedguide/leukemia-chronic-myeloid-myelogenous-treating-targeted-therapies. Last updated 9/23/2013e. Accessed 08/09/2014.
12.ACS. American Cancer Society. What Are The Risk Factors For Acute Myelogenous Leukemia (AML): Certain Blood Disorders. Available at: http://www.cancer.org/cancer/leukemia-acutemyeloidaml/detailedguide/leukemia-acute-myeloid-myelogenous-risk-factors. Last updated 7/24/2013a. Accessed 8/19/2014.
13.ACS. American Cancer Society. What are the key statistics about myelodysplastic syndromes? Available at: http://www.cancer.org/cancer/myelodysplasticsyndrome/detailedguide/myelodysplastic-syndromes-key-statistics. Last updated 2/10/2014g. Accessed 9/5/2014.
14.Advani AMS, Coutre S, et al. Southwest Oncology Group Study S0910: A Phase 2 Trial of Clofarabine/Cytarabine/Epratuzumab for Relapsed/Refractory Acute Lymphocytic Leukemia. Blood (ASH Annual Meeting Abstracts) 2012, 120:2603.
15.Aggarwal BB, Ichikawa H. Molecular targets and anticancer potential of indole-3-carbinol and its derivatives. Cell Cycle. 2005 Sep;4(9):1201-15.
16.Aggarwal BB, Kumar A, Bharti AC. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res. 2003 Jan-Feb;23(1A):363-98.
17.Agis H, Sperr WR, Herndlhofer S, Semper H, Pirc-Danoewinata H, Haas OA, . . . Valent P. Clinical and prognostic significance of histamine monitoring in patients with CML during treatment with imatinib (STI571). Annals of oncology: official journal of the European Society for Medical Oncology / ESMO. Nov 2007;18(11):1834-1841.
18.Ahmad A, Ahmad R. Resveratrol mitigate structural changes and hepatic stellate cell activation in N'-nitrosodimethylamine-induced liver fibrosis via restraining oxidative damage. Chemico-biological interactions. Jul 24 2014;221c:1-12.
19.Ahmed N, Laverick L, et al. Ajoene, a garlic-derived natural compound, enhances chemotherapy-induced apoptosis in human myeloid leukaemia CD34-positive resistant cells. Anticancer Res. 2001 Sep-Oct;21(5):3519-23.
20.Alaikov T, Konstantinov SM, et al. Antineoplastic and anticlastogenic properties of curcumin. Ann N Y Acad Sci. 2007 Jan;1095:355-70.
21.Aldoss I, Mark L, Vrona J, Ramezani L, Weitz I, Mohrbacher AM, Douer D. Adding ascorbic acid to arsenic trioxide produces limited benefit in patients with acute myeloid leukemia excluding acute promyelocytic leukemia. Annals of hematology. Jun 7 2014.
22.Altucci L, Rossin A, et al. Retinoic acid-induced apoptosis in leukemia cells is mediated by paracrine action of tumor-selective death ligand TRAIL. Nat Med. 2001 Jun;7(6):680-6.
23.Anand P, Sundaram C, et al. Curcumin and cancer: an "old-age" disease with an "age-old" solution. Cancer Lett. 2008 Aug 18;267(1):133-64.
24.Anderson KM, Seed T, et al. Selective inhibitors of 5-lipoxygenase reduce CML blast cell proliferation and induce limited differentiation and apoptosis. Leuk Res. 1995 Nov;19(11):789-801.
25.Anderson KM, Seed T, Jajeh A, Dudeja P, Byun T, Meng J, . . . Harris JE. An in vivo inhibitor of 5-lipoxygenase, MK886, at micromolar concentration induces apoptosis in U937 and CML cells. Anticancer research. Sep-Oct 1996;16(5a):2589-2599.
26.Angelo LS, Kurzrock R. Turmeric and green tea: a recipe for the treatment of B-chronic lymphocytic leukemia. Clin Cancer Res. 2009 Feb 15;15(4):1123-5.
27.ARSPI. The Alliance for Radiation Safety in Pediatric Imaging. Campaign Overview. Available at: http://www.imagegently.org/FAQsMore/CampaignOverview.aspx. Accessed 08/08/2014. http://www.imagegently.org/FAQsMore/CampaignOverview.aspx.
28.ASCO. American Society of Clinical Oncology. Navigating Cancer Care page. What is Stem Cell/Bone Marrow Transplantation? Available at: http://www.cancer.net/navigating-cancer-care/how-cancer-treated/bone-marrowstem-cell-transplantation/what-stem-cellbone-marrow-transplantation. Accessed 08/12/2014.
29.ASH. American Society of Hematology. 51st ASH Annual Meeting and Exposition. Online Program and Abstracts. 790 Preliminary Results of Southwest Oncology Group Study S0106: An International Intergroup Phase 3 Randomized Trial Comparing the Addition of Gemtuzumab Ozogamicin to Standard Induction Therapy Versus Standard Induction Therapy Followed by a Second Randomization to Post-Consolidation Gemtuzumab Ozogamicin Versus No Additional Therapy for Previously Untreated Acute Myeloid Leukemia Available at: https://ash.confex.com/ash/2009/webprogram/Paper22999.html. Paper presented at: 51st ASH Annual Meeting and Exposition. 2009; New Orleans, LA. Accessed 08/09/2014.
30.Baccarani M, Castagnetti F, et al. Treatment Recommendations for Chronic Myeloid Leukemia. Mediterr J Hematol Infect Dis. 2014 Jan 2;6(1):e2014005.
31.Baccarani M, Cortes J, et al. Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet. J Clin Oncol. 2009 Dec 10;27(35):6041-51.
32.Bailey HD, Miller M, Langridge A, de Klerk NH, van Bockxmeer FM, Attia J, . . . Milne E. Maternal dietary intake of folate and vitamins B6 and B12 during pregnancy and the risk of childhood acute lymphoblastic leukemia. Nutrition and cancer. 2012;64(7):1122-1130.
33.Balasubramanian S, Eckert RL. Keratinocyte proliferation, differentiation, and apoptosis--differential mechanisms of regulation by curcumin, EGCG and apigenin. Toxicol Appl Pharmacol. 2007 Nov 1;224(3):214-9.
34.Bansal S, Prabhash K, Parikh P. Chronic myeloid leukemia data from India. Indian journal of medical and paediatric oncology: official journal of Indian Society of Medical & Paediatric Oncology. Jul 2013;34(3):154-158.
35.Bartley K, Metayer C, Selvin S, Ducore J, Buffler P. Diagnostic X-rays and risk of childhood leukaemia. International journal of epidemiology. Dec 2010;39(6):1628-1637.
36.Baumann Kreuziger LM, Tarchand G, Morrison VA. The impact of Agent Orange exposure on presentation and prognosis of patients with chronic lymphocytic leukemia. Leukemia & lymphoma. Jan 2014;55(1):63-66.
37.Bedi A, Zehnbauer BA, Barber JP, Sharkis SJ, Jones RJ. Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia. Blood. Apr 15 1994;83(8):2038-2044.
38.Begum M, Jahan S, Tawfique M, Mannan MA. Out come of induction of remission in undernourished children with acute lymphoblastic leukaemia. Mymensingh medical journal: MMJ. Oct 2012;21(4):691-695.
39.Beltran B, Salas R, Quinones P, Morales D, Hurtado F, Cotrina E, . . . Castillo J. EBV-positive diffuse large B-cell lymphoma in a human T-lymphotropic virus type 1 carrier. Infectious agents and cancer. 2009;4:10.
40.Benabadji SH, Wen R, Zheng JB, Dong XC, Yuan SG. Anticarcinogenic and antioxidant activity of diindolylmethane derivatives. Acta pharmacologica Sinica. May 2004;25(5):666-671.
41.Bleakley M, Heimfeld S, Loeb KR, et al. Outcomes of acute leukemia patients transplanted with naive T cell–depleted stem cell grafts. The Journal of Clinical Investigation. 07/01/ 2015;125(7):2677-2689. doi:10.1172/JCI81229
42.Bleakley M, Sehgal A, Seropian S, et al. Naive T-Cell Depletion to Prevent Chronic Graft-Versus-Host Disease. J Clin Oncol. Jan 10 2022:Jco2101755. doi:10.1200/jco.21.01755
43.Borriello A, Bencivenga D, Caldarelli I, et al. Resveratrol: from basic studies to bedside. Cancer Treat Res. 2014;159:167-84.
44.Breccia M, Alimena G. Second-Generation Tyrosine Kinase Inhibitors (Tki) as Salvage Therapy for Resistant or Intolerant Patients to Prior TKIs. Mediterr J Hematol Infect Dis. 2014 Jan 2;6(1):e2014003.
45.Breccia M, Cicconi L, Lo-Coco F. ATRA + ATO: has a new standard of care been established in low-risk acute promyelocytic leukaemia? Current opinion in hematology. Mar 2014;21(2):95-101.
46.Brownson RC, Novotny TE, Perry MC. Cigarette smoking and adult leukemia. A meta-analysis. Arch Intern Med. 1993 Feb 22;153(4):469-75.
47.Brugnone F, Perbellini L, Romeo L, Cerpelloni M, Cecco A, Leopard Barra E, . . . Ferracin A. [Environmental exposure and blood levels of benzene in gas station attendants. Comparison with the general population]. La Medicina del lavoro. Mar-Apr 1997;88(2):131-147.
48.Bryan M, Pulte ED, Toomey KC, Pliner L, Pavlick AC, Saunders T, Wieder R. A pilot phase II trial of all-trans retinoic acid (Vesanoid) and paclitaxel (Taxol) in patients with recurrent or metastatic breast cancer. Investigational new drugs. Dec 2011;29(6):1482-1487.
49.Budhraja A, Gao N, et al. Apigenin induces apoptosis in human leukemia cells and exhibits anti-leukemic activity in vivo. Mol Cancer Ther. 2012 Jan;11(1):132-42.
50.Bunce CM, Brown G, et al. Vitamin D and hematopoiesis. Trends Endocrinol Metab. 1997 Aug;8(6):245-51.
51.Bushue N, Wan YJ. Retinoid pathway and cancer therapeutics. Advanced drug delivery reviews. Oct 30 2010;62(13):1285-1298.
52.Buss NA, Henderson SJ, McFarlane M, Shenton JM, de Haan L. Monoclonal antibody therapeutics: history and future. Current opinion in pharmacology. Oct 2012;12(5):615-622.
53.Calviello G, Serini S, et al. Antineoplastic effects of n-3 polyunsaturated fatty acids in combination with drugs and radiotherapy: preventive and therapeutic strategies. Nutr Cancer. 2009;61(3):287-301.
54.Can G, Cakir Z, et al. Apoptotic effects of resveratrol, a grape polyphenol, on imatinib-sensitive and resistant K562 chronic myeloid leukemia cells. Anticancer Res. 2012 Jul;32(7):2673-8.
55.Cao LZ, Lin ZB. Regulation on maturation and function of dendritic cells by Ganoderma lucidum polysaccharides. Immunol Lett. 2002 Oct 1;83(3):163-9.
56.Cardeno A, Sanchez-Hidalgo M, Cortes-Delgado A, Alarcon de la Lastra C. Mechanisms involved in the antiproliferative and proapoptotic effects of unsaponifiable fraction of extra virgin olive oil on HT-29 cancer cells. Nutrition and cancer. 2013;65(6):908-918.
57.Casaburi I, Puoci F, Chimento A, Sirianni R, Ruggiero C, Avena P, Pezzi V. Potential of olive oil phenols as chemopreventive and therapeutic agents against cancer: a review of in vitro studies. Molecular nutrition & food research. Jan 2013;57(1):71-83.
58.Cavallo J. Incidence of Chronic Graft-vs-Host Disease: Effect of Depleting Naive T Cells From Peripheral Blood Stem Cell Allografts in Patients with Leukemia. HSP News Service, L.L.C. Updated 1/11/2022. Accessed 1/13/2022, https://ascopost.com/news/january-2022/incidence-of-chronic-graft-vs-host-disease-effect-of-depleting-naive-t-cells-from-peripheral-blood-stem-cell-allografts-in-patients-with-leukemia/
59.CCS. Canadian Cancer Society. Cancer Information page. Side Effects of Chemotherapy. Available at http://www.cancer.ca/en/cancer-information/diagnosis-and-treatment/chemotherapy-and-other-drug-therapies/chemotherapy/side-effects-of-chemotherapy/. Copyright © 2014. Accessed 08/08/2014.
60.Chan WK, Lam DT, Law HK, et al. Ganoderma lucidum mycelium and spore extracts as natural adjuvants for immunotherapy. J Altern Complement Med. 2005 Dec;11(6):1047-57.
61.Chang JS, Selvin S, et al. Parental smoking and the risk of childhood leukemia. Am J Epidemiol. 2006 Jun 15;163(12):1091-100.
62.Checkoway H, Boffetta P, Mundt DJ, Mundt KA. Critical review and synthesis of the epidemiologic evidence on formaldehyde exposure and risk of leukemia and other lymphohematopoietic malignancies. Cancer causes & control: CCC. Nov 2012;23(11):1747-1766.
63.Chen H, Tuck T, Ji X, Zhou X, Kelly G, Cuerrier A, Zhang J. Quality assessment of Japanese knotweed (Fallopia japonica) grown on Prince Edward Island as a source of resveratrol. Journal of agricultural and food chemistry. Jul 3 2013;61(26):6383-6392.
64.Chen L, Wang J, Hu X, Xu X. Meta-analysis of all-trans retinoic acid-linked arsenic trioxide treatment for acute promyelocytic leukemia. Hematology (Amsterdam, Netherlands). Jun 2014;19(4):202-207.
65.Chen Y, Hu Y, Michaels S, et al. Inhibitory effects of omacetaxine on leukemic stem cells and BCR-ABL-induced chronic myeloid leukemia and acute lymphoblastic leukemia in mice. Leukemia. 2009 Aug;23(8):1446-54.
66.Chen Y, Hu Y, Zhang H, et al. Loss of the Alox5 gene impairs leukemia stem cells and prevents chronic myeloid leukemia. Nat Genet. 2009 Jul;41(7):783-92.
67.Chen Y, Peng C, et al. Novel therapeutic agents against cancer stem cells of chronic myeloid leukemia. Anticancer Agents Med Chem. 2010 Feb;10(2):111-5.
68.Cho WC, Leung KN. In vitro and in vivo immunomodulating and immunorestorative effects of Astragalus membranaceus. J Ethnopharmacol. 2007a Aug 15;113(1):132-41.
69.Cho WC, Leung KN. In vitro and in vivo anti-tumor effects of Astragalus membranaceus. Cancer Lett. 2007b Jul 8;252(1):43-54.
70.Choi WY, Choi BT, et al. Sulforaphane generates reactive oxygen species leading to mitochondrial perturbation for apoptosis in human leukemia U937 cells. Biomed Pharmacother. 2008 Nov;62(9):637-44.
71.CIRM. California Institute for Regenerative Medicine. Stem cell differentiation and the Cancer Stem Cell Hypothesis. Available at: http://www.cirm.ca.gov/our-progress/advanced-stem-cell-differentiation-and-cancer-stem-cell-hypothesis. Copyright © 2013. Accessed 9/23/2014.
72.Clavel J, Sermage-Faure C, Demoury C, Rudant J, Goujon-Bellec S, Guyot-Goubin A, . . . Hemon D. Reply: comment on 'Childhood leukaemia close to high-voltage power lines--the Geocap study, 2002-2007'--is proximity an appropriate MF exposure surrogate? British journal of cancer. Sep 3 2013;109(5):1383-1384.
73.Cleveland Clinic. Health Information page. Diseases & Conditions. Myelodysplastic Syndrome Overview. Available at: http://my.clevelandclinic.org/disorders/myelodysplastic/bm_overview.aspx. Accessed 5/15/2014.
74.Connell PP, Weichselbaum RR. Small molecule derived from a natural product that mitigates radiation injury. Proceedings of the National Academy of Sciences of the United States of America. Nov 12 2013;110(46):18355-18356.
75.Contractor R, Samudio IJ, Estrov Z, Harris D, McCubrey JA, Safe SH, . . . Konopleva M. A novel ring-substituted diindolylmethane,1,1-bis[3'-(5-methoxyindolyl)]-1-(p-t-butylphenyl) methane, inhibits extracellular signal-regulated kinase activation and induces apoptosis in acute myelogenous leukemia. Cancer research. Apr 1 2005;65(7):2890-2898.
76.Cortes JE, Kim DW, et al. A phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemias. N Engl J Med. 2013 Nov 7;369(19):1783-96.
77.Cowan AJ, Laszlo GS, Estey EH, et al. Antibody-based therapy of acute myeloid leukemia with gemtuzumab ozogamicin. Front Biosci (Landmark Ed). 2013;18:1311-1334.
78.Cragg GM, Newman DJ, et al. Natural product extracts of plant and marine origin having antileukemia potential. The NCI experience. J Nat Prod. 2006 Mar;69(3):488-98.
79.Crews LA, Jamieson CH. Selective elimination of leukemia stem cells: hitting a moving target. Cancer letters. Sep 10 2013;338(1):15-22.
80.Cripe LD. Adult acute leukemia. Current problems in cancer. Jan-Feb 1997;21(1):1-64.
81.Cyopick P, Culliton R, Brockhausen I, Sutherland DR, Mills GB, Baker M. Role of aberrant sialylation of chronic myeloid leukemia granulocytes on binding and signal transduction by chemotactic peptides and colony stimulating factors. Leukemia & lymphoma. Sep 1993;11(1-2):79-90.
82.Dao KH, Tyner JW. Next-generation medicine: combining BCR-ABL and Hedgehog-targeted therapies. Clin Cancer Res. 2013 Mar 15;19(6):1309-11.
83.Das PP, Shaik AP, Jamil K. Genotoxicity induced by pesticide mixtures: in-vitro studies on human peripheral blood lymphocytes. Toxicology and industrial health. Sep 2007;23(8):449-458.
84.Davila ML, Riviere I, et al. Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia. Sci Transl Med. 2014 Feb 19;6(224):224ra25.
85.Davila ML, Kloss CC, Gunset G, Sadelain M. CD19 CAR-targeted T cells induce long-term remission and B Cell Aplasia in an immunocompetent mouse model of B cell acute lymphoblastic leukemia. PloS one. 2013;8(4):e61338.
86.Davoli E, Cappellini L, Moggi M, Ferrari S, Fanelli R. On-line monitoring of benzene air concentrations while driving in traffic by means of isotopic dilution gas chromatography/mass spectrometry. International archives of occupational and environmental health. 1996;68(4):262-267.
87.de Lima TM, Amarante-Mendes GP, Curi R. Docosahexaenoic acid enhances the toxic effect of imatinib on Bcr-Abl expressing HL-60 cells. Toxicol In vitro. 2007; 21:1678-85.
88.De Pergola G, Silvestris F. Obesity as a major risk factor for cancer. J Obes. 2013;2013:291546.
89.Debnam JM, Schellingerhout D, Kumar AJ, Ketonen L, Shah K, Hamberg LM, Hunter GJ. Multidetector CT-Guided Lumbar Puncture in Patients with Cancer. Interventional neuroradiology: journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences. Mar 31 2009;15(1):61-66.
90.Deininger M, Buchdunger E. The development of imatinib as a therapeutic agent for chronic myeloid leukemia. Blood. 2005 Apr 1;105(7):2640-53.
91.Den Boer ML, van Slegtenhorst M, De Menezes RX, Cheok MH, Buijs-Gladdines JG, Peters ST, . . . Pieters R. A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study. The lancet oncology. Feb 2009;10(2):125-134.
92.Dennis M, Davies M, et al. Phase I study of the Aurora B kinase inhibitor barasertib (AZD1152) to assess the pharmacokinetics, metabolism and excretion in patients with acute myeloid leukemia. Cancer Chemother Pharmacol. 2012 Sep;70(3):461-9.
93.Di Bella G, Mascia F, et al. Melatonin anticancer effects: review. Int J Mol Sci. 2013 Jan 24;14(2):2410-30.
94.Diaz PR, Neira LC, Fischer SG, Teresa Torres MC, Milinarsky AT, Giadrosich VR, . . . Casanova DM. Effect of 1,25(OH)2-vitamin D on bone mass in children with acute lymphoblastic leukemia. Journal of pediatric hematology/oncology. Jan 2008;30(1):15-19.
95.Dierks C, Beigi R, et al. Expansion of Bcr-Abl-positive leukemic stem cells is dependent on Hedgehog pathway activation. Cancer Cell. 2008 Sep 9;14(3):238-49.
96.Dirsch VM, Antlsperger DS, et al. Ajoene, an experimental anti-leukemic drug: mechanism of cell death. Leukemia. 2002 Jan;16(1):74-83.
97.Doane L. Overview of tumor lysis syndrome. Semin Oncol Nurs. 2002 Aug;18(3 Suppl 3):2-5.
98.Dong J, Gu HL, et al. [Effects of large dose of Astragalus membranaceus on the dendritic cell induction of peripheral mononuclear cell and antigen presenting ability of dendritic cells in children with acute leukemia]. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2005 Oct;25(10):872-5.
99.Dorantes-Acosta E, Medina-Sanson A, et al. Clinical features and treatment outcomes of pediatric acute promyelocytic leukemia in a Mexican pediatric hospital. Rev Invest Clin. 2013 Sep-Oct;65(5):392-8.
100.Dörrie J, Gerauer H, et al. Resveratrol induces extensive apoptosis by depolarizing mitochondrial membranes and activating caspase-9 in acute lymphoblastic leukemia cells. Cancer Res. 2001 Jun 15;61(12):4731-9.
101.Dotti G, Garattini E, et al. Leucocyte alkaline phosphatase identifies terminally differentiated normal neutrophils and its lack in chronic myeloid leukaemia is not dependent on p210 tyrosine kinase activity. Br J Haematol. 1999 Apr;105(1):163-72.
102.Doudican NA, Bowling B, Orlow SJ. Enhancement of arsenic trioxide cytotoxicity by dietary isothiocyanates in human leukemic cells via a reactive oxygen species-dependent mechanism. Leuk Res. 2010 Feb;34(2):229-34.
103.Druker BJ, Guilhot F,et al. Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. N Engl J Med. 2006 Dec 7;355(23):2408-17.
104.Druker BJ, Talpaz M, et al. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med. 2001 Apr 5;344(14):1031-7.
105.Druker BJ, Tamura S, et al. Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells. Nat Med. 1996 May;2(5):561-6.
106.Duvoix A, Blasius R, et al. Chemopreventive and therapeutic effects of curcumin. Cancer Lett. 2005 Jun 8;223(2):181-90.
107.Duvoix A, Morceau F, et al. Curcumin-induced cell death in two leukemia cell lines: K562 and Jurkat. Ann N Y Acad Sci. 2003 Dec;1010:389-92.
108.Elia M, Van Bokhorst-de van der Schueren MA, et al. Enteral (oral or tube administration) nutritional support and eicosapentaenoic acid in patients with cancer: a systematic review. Int J Oncol.2006;28:5-23.
109.El-Sokkary GH, Reiter RJ. et al. Melatonin supplementation restores cellular proliferation and DNA synthesis in the splenic and thymic lymphocytes of old rats. Neuro Endocrinol Lett. 2003 Jun;24(3-4):215-23.
110.Escrich E, Solanas M, Moral R. Olive oil and other dietary lipids in breast cancer. Cancer treatment and research. 2014;159:289-309.
111.Estey E. High cytogenetic or molecular genetic risk acute myeloid leukemia. Hematology Am Soc Hematol Educ Program. 2010;2010:474-80.
112.Estrov Z, Shishodia S, et al. Resveratrol blocks interleukin-1beta-induced activation of the nuclear transcription factor NF-kappaB, inhibits proliferation, causes S-phase arrest, and induces apoptosis of acute myeloid leukemia cells. Blood. 2003 Aug 1;102(3):987-95.
113.Ezzone SA. Tumor lysis syndrome. Semin Oncol Nurs. 1999 Aug;15(3):202-8.
114.Fabiani R, De Bartolomeo A, et al. Cancer chemoprevention by hydroxytyrosol isolated from virgin olive oil through G1 cell cycle arrest and apoptosis. Eur J Cancer Prev. 2002 Aug;11(4):351-8.
115.Fabiani R, De Bartolomeo A, et al. Virgin olive oil phenols inhibit proliferation of human promyelocytic leukemia cells (HL60) by inducing apoptosis and differentiation. J Nutr. 2006 Mar;136(3):614-9.
116.Fabiani R, Rosignoli P, et al. Oxidative DNA damage is prevented by extracts of olive oil, hydroxytyrosol, and other olive phenolic compounds in human blood mononuclear cells and HL60 cells. J Nutr. 2008 Aug;138(8):1411-6.
117.Fahrmann JF, Ballester OF, Ballester G, Witte TR, Salazar AJ, Kordusky B, . . . Hardman WE. Inhibition of nuclear factor kappa B activation in early-stage chronic lymphocytic leukemia by omega-3 fatty acids. Cancer investigation. Jan 2013;31(1):24-38.
118.Fan S, Meng Q, Xu J, Jiao Y, Zhao L, Zhang X, . . . Rosen EM. DIM (3,3'-diindolylmethane) confers protection against ionizing radiation by a unique mechanism. Proceedings of the National Academy of Sciences of the United States of America. Nov 12 2013;110(46):18650-18655.
119.Fei F, Lim M, Schmidhuber S, Moll J, Groffen J, Heisterkamp N. Treatment of human pre-B acute lymphoblastic leukemia with the Aurora kinase inhibitor PHA-739358 (Danusertib). Molecular cancer. 2012;11:42.
120.Fellner C. Vismodegib (erivedge) for advanced Basal cell carcinoma. P T. 2012 Dec;37(12):670-82.
121.Ferreira JD, Couto AC, Pombo-de-Oliveira MS, Koifman S. In utero pesticide exposure and leukemia in Brazilian children < 2 years of age. Environmental health perspectives. Feb 2013;121(2):269-275.
122.Ferri FF. Ferri's Clinical Advisor. Leukamia, Acute Myelogenous. Available at: www.clinicalkey.com. Copyright © 2014. Accessed 4/17/2014.
123.Fielding AK. How I treat Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood. Nov 4 2010;116(18):3409-3417.
124.Fimognari C, Lenzi M, et al. Induction of differentiation in human promyelocytic cells by the isothiocyanate sulforaphane. In Vivo. 2008 May-Jun;22(3):317-20.
125.Flombaum CD. Metabolic emergencies in the cancer patient. Semin Oncol. 2000 Jun;27(3):322-34.
126.Foran J, Ravandi F, et al. Phase I and Pharmacodynamic Study of AT9283, a Small-Molecule Inhibitor of Aurora Kinases in Patients With Relapsed/Refractory Leukemia or Myelofibrosis. Clin Lymphoma Myeloma Leuk. 2014;14(3):223-30.
127.Foroni L, Gerrard G, et al. Technical aspects and clinical applications of measuring BCR-ABL1 transcripts number in chronic myeloid leukemia. Am J Hematol. 2009 Aug;84(8):517-22.
128.Fresco P, Borges F, et al. The anticancer properties of dietary polyphenols and its relation with apoptosis. Curr Pharm Des. 2010 Jan;16(1):114-34.
129.Fukuzawa M, Yamaguchi R, et al. Possible involvement of long chain fatty acids in the spores of Ganoderma lucidum (Reishi Houshi) to its anti-tumor activity. Biol Pharm Bull. 2008 Oct;31(10):1933-7.
130.Gajjar A, Harrison PL, Sandlund JT, Rivera GK, Ribeiro RC, Rubnitz JE, . . . Pui CH. Traumatic lumbar puncture at diagnosis adversely affects outcome in childhood acute lymphoblastic leukemia. Blood. Nov 15 2000;96(10):3381-3384.
131.Gao P, Hirano T, et al. Isolation and identification of C-19 fatty acids with anti-tumor activity from the spores of Ganoderma lucidum (reishi mushroom). Fitoterapia. 2012 Apr;83(3):490-9.
132.Gao Y, Zhou S, Jiang W, Huang M, Dai X. Effects of ganopoly (a Ganoderma lucidum polysaccharide extract) on the immune functions in advanced-stage cancer patients. Immunol Invest. 2003 Aug;32(3):201-15.
133.Garcia-Manero G. Myelodysplastic syndromes: 2014 update on diagnosis, risk-stratification, and management. Am J Hematol. 2014 Jan;89(1):97-108.
134.Gautam SC, Xu YX, et al. Resveratrol selectively inhibits leukemia cells: a prospective agent for ex vivo bone marrow purging. Bone Marrow Transplant. 2000;25:639-645.
135.Gentry PR, Rodricks JV, Turnbull D, Bachand A, Van Landingham C, Shipp AM, . . . Irons R. Formaldehyde exposure and leukemia: critical review and reevaluation of the results from a study that is the focus for evidence of biological plausibility. Critical reviews in toxicology. Sep 2013;43(8):661-670.
136.Ghalaut VS, Sangwan L, et al. Effect of imatinib therapy with and without turmeric powder on nitric oxide levels in chronic myeloid leukemia. J Oncol Pharm Pract. 2012 Jun;18(2):186-90.
137.Ghosh AK, Kay NE, et al. Curcumin inhibits prosurvival pathways in chronic lymphocytic leukemia B cells and may overcome their stromal protection in combination with EGCG. Clin Cancer Res. 2009 Feb 15;15(4):1250-8.
138.Gilliland DG, Griffin JD. The roles of FLT3 in hematopoiesis and leukemia. Blood. 2002 Sep 1;100(5):1532-42.
139.Gobel BH. Management of tumor lysis syndrome: prevention and treatment. Semin Oncol Nurs. 2002 Aug;18(3 Suppl 3):12-6.
140.Gocek E, Baurska H, Marchwicka a, et al. Regulation of Leukemic Cell Differentiation through the Vitamin D Receptor at the Levels of Intracellular Signal Transduction, Gene Transcription, and Protein Trafficking and Stability. Leukemia Research and Treatment. 2012:1-11.
141.Gogos CA, Ginopoulos P, et al. Dietary omega-3 polyunsaturated fatty acids plus vitamin E restore immunodeficiency and prolong survival for severely ill patients with generalized malignancy: a randomized control trial. Cancer. 1998 Jan 15;82(2):395-402.
142.Gokbulut AA, Apohan E, Baran Y. Resveratrol and quercetin-induced apoptosis of human 232B4 chronic lymphocytic leukemia cells by activation of caspase-3 and cell cycle arrest. Hematology (Amsterdam, Netherlands). May 2013;18(3):144-150.
143.Goldenson B, Crispino JD. The aurora kinases in cell cycle and leukemia. Oncogene. 2014 Mar 17.
144.Goldman JM, Melo JV. BCR-ABL in chronic myelogenous leukemia--how does it work? Acta haematologica. 2008;119(4):212-217.
145.Goldman L, Schafer AI. The Acute Leukemias. In: Goldman's Cecil Medicine, Twenty-Fourth Edition. Available at: www.clinicalkey.com. Copyright © 2012a. Accessed 4/21/2014.
146.Goldman L, Schafer AI. The Chronic Leukemias. In: Goldman's Cecil Medicine, Twenty-Fourth Edition. Available at: www.clinicalkey.com. Copyright © 2012b. Accessed 4/21/2014.
147.Gonçalves AC, Alves V, et al. Oxidative stress mediates apoptotic effects of ascorbate and dehydroascorbate in human Myelodysplasia cells in vitro. Toxicol In Vitro. 2013 Aug;27(5):1542-9.
148.Gonzalez-Mejia ME, Voss OH, Murnan EJ, et al. Apigenin-induced apoptosis of leukemia cells is mediated by a biomodal and differentially regulated residue-specific phosphorylation of heat-shock protein-27. Cell Death Dis. 2010;1(8):e64.
149.Gordois A, Scuffham P, et al. Cost-utility analysis of imatinib mesilate for the treatment of advanced stage chronic myeloid leukaemia. Br J Cancer. 2003 Aug 18;89(4):634-40.
150.Gradishar WJ, Schilsky RL. Effects of cancer treatment on the reproductive system. Critical reviews in oncology/hematology. 1988;8(2):153-171.
151.Granzotto M, Rapozzi V. et al. Effects of melatonin on doxorubicin cytotoxicity in sensitive and pleiotropically resistant tumor cells. J Pineal Res. 2001 Oct;31(3):206-13.
152.Grupp SA, Kalos M, et al. Chimeric antigen receptor-modified T cells for acute lymphoid leukemia. N Engl J Med. 2013 Apr 18;368(16):1509-18.
153.Gruschkus SK, Lairson D, et al. Use of white blood cell growth factors and risk of acute myeloid leukemia or myelodysplastic syndrome among elderly patients with non-Hodgkin lymphoma. Cancer. 2010 Nov 15;116(22):5279-89.
154.Gudas LJ, Wagner JA. Retinoids regulate stem cell differentiation. Journal of cellular physiology. Feb 2011;226(2):322-330.
155.Guo JQ, Lian J, Glassman A, Talpaz M, Kantarjian H, Deisseroth AB, Arlinghaus RB. Comparison of bcr-abl protein expression and Philadelphia chromosome analyses in chronic myelogenous leukemia patients. American journal of clinical pathology. Oct 1996;106(4):442-448.
156.Gupta SC, Kannappan R, et al. Chemosensitization of tumors by resveratrol. Ann N Y Acad Sci. 2011 Jan;1215:150-60.
157.Haimov I, Lavie P. Melatonin - a chronobiotic and soporific hormone. Arch Gerontol Geriatr. 1997 Mar;24(2):167-73.
158.Hall AC, Juckett MB. The role of vitamin d in hematologic disease and stem cell transplantation. Nutrients. 2013 Jun 18;5(6):2206-21.
159.Han DH, Jeong JH, Kim JH. Anti-proliferative and apoptosis induction activity of green tea polyphenols on human promyelocytic leukemia HL-60 cells. Anticancer Res. 2009 Apr;29(4):1417-21.
160.Harakeh S, Diab-Assaf M, Khalife JC, Abu-el-Ardat KA, Baydoun E, Niedzwiecki A, . . . Rath M. Ascorbic acid induces apoptosis in adult T-cell leukemia. Anticancer research. Jan-Feb 2007;27(1a):289-298.
161.Hartsink-Segers SA, Zwaan CM, et al. Aurora kinases in childhood acute leukemia: the promise of aurora B as therapeutic target. Leukemia. 2013 Mar;27(3):560-8.
162.Hassan HT. Ajoene (natural garlic compound): a new anti-leukaemia agent for AML therapy. Leuk Res. 2004 Jul;28(7):667-71.
163.Hayes RB, Songnian Y, et al. Benzene and lymphohematopoietic malignancies in humans. Am J Ind Med. 2001 Aug;40(2):117-26.
164.Hayun R, Okun E, et al. Rapamycin and curcumin induce apoptosis in primary resting B chronic lymphocytic leukemia cells. Leuk Lymphoma. 2009 Apr;50(4):625-32.
165.Helms S. Cancer prevention and therapeutics: Panax ginseng. Alternative medicine review : a journal of clinical therapeutic. Sep 2004;9(3):259-274.
166.Herlofson BB, Norman-Pedersen K, Redfors M, Fossa SD. Oral mucosal side effects of cytotoxic chemotherapy of testicular cancer. A retrospective study. European journal of oral sciences. Oct 1997;105(5 Pt 2):523-526.
167.Hochhaus A, Kantarjian H. The development of dasatinib as a treatment for chronic myeloid leukemia (CML): from initial studies to application in newly diagnosed patients. J Cancer Res Clin Oncol. 2013 Dec;139(12):1971-84.
168.Hoelzer DHA, Kaul F. Immunochemotherapy with rituximab improves molecular CR rate and outcome in CD20+ B-lineage standard and high risk patients; results of 263 CD20+ patients studied prospectively in GMALL study 07/2003. Blood (ASH Annual Meeting Abstracts) 2010, 116:170.
169.Hoffmann-La Roche. A PHASE 1B/II STUDY TO EVALUATE THE SAFETY AND EFFICACY OF VISMODEGIB IN RELAPSED/REFRACTORY ACUTE MYELOGENOUS LEUKEMIA (AML) AND RELAPSED/REFRACTORY HIGH-RISK MYELODYSPLASTIC SYNDROME (MDS). Available at: http://clinicaltrials.gov/show/NCT01880437. 2014. NLM Identifier: NCT01880437.
170.Hsieh TC, Wu JM. Regulation of cell cycle transition and induction of apoptosis in HL-60 leukemia cells by the combination of Coriolus versicolor and Ganoderma lucidum. International journal of molecular medicine. Jul 2013;32(1):251-257.
171.Hsu JW, Huang HC, Chen ST, Wong CH, Juan HF. Ganoderma lucidum Polysaccharides Induce Macrophage-Like Differentiation in Human Leukemia THP-1 Cells via Caspase and p53 Activation. Evidence-based complementary and alternative medicine: eCAM. 2011;2011:358717.
172.Hsu WL, Preston DL, et al. The incidence of leukemia, lymphoma and multiple myeloma among atomic bomb survivors: 1950-2001. Radiat Res. 2013 Mar;179(3):361-82.
173.Hu J, Liu YF, et al. Long-term efficacy and safety of all-trans retinoic acid/arsenic trioxide-based therapy in newly diagnosed acute promyelocytic leukemia. Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3342-7.
174.Huang H, Jia Q, Ma J, Qin G, Chen Y, Xi Y, . . . Liu H. Discovering novel quercetin-3-O-amino acid-esters as a new class of Src tyrosine kinase inhibitors. European journal of medicinal chemistry. May 2009;44(5):1982-1988.
175.Huang LH, Yan QJ, et al. Astragalus membranaceus lectin (AML) induces caspase-dependent apoptosis in human leukemia cells. Cell Prolif. 2012 Feb;45(1):15-21.
176.Huang WY, Cai YZ, Zhang Y. Natural phenolic compounds from medicinal herbs and dietary plants: potential use for cancer prevention. Nutr Cancer. 2010;62(1):1-20.
177.Huang YT, Hwang JJ, Lee PP, Ke FC, Huang JH, Huang CJ, . . . Lee MT. Effects of luteolin and quercetin, inhibitors of tyrosine kinase, on cell growth and metastasis-associated properties in A431 cells overexpressing epidermal growth factor receptor. British journal of pharmacology. Nov 1999;128(5):999-1010.
178.Hughes PJ, Marcinkowska E, et al. Vitamin D3-driven signals for myeloid cell differentiation--implications for differentiation therapy. Leuk Res. 2010 May;34(5):553-65.
179.Huh HJ, Lee SH, et al. Therapy-related myeloid neoplasms in 39 Korean patients: a single institution experience. Ann Lab Med. 2013 Mar;33(2):97-104.
180.Hunger SP, Lu X, Devidas M, Camitta BM, Gaynon PS, Winick NJ, . . . Carroll WL. Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children's oncology group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. May 10 2012;30(14):1663-1669.
181.Iqbal Ahmed CM, Johnson HM. Interferon gene therapy for the treatment of cancer and viral infections. Drugs Today (Barc). 2003 Oct;39(10):763-6.
182.Iseki T. [Vitamin B12 and transcobalamin in chronic myeloproliferative disorders]. Rinsho byori. The Japanese journal of clinical pathology. Dec 1993;41(12):1310-1321.
183.Jaglowski SM, Byrd JC. Novel therapies and their integration into allogeneic stem cell transplant for chronic lymphocytic leukemia. Biol Blood Marrow Transplant. 2012 Jan;18(1 Suppl):S132-8.
184.Jaglowski SM, Byrd JC. Rituximab in chronic lymphocytic leukemia. Seminars in hematology. Apr 2010;47(2):156-169.
185.Jan RH, Lin TY, Hsu YC, et al. Immuno-modulatory activity of Ganoderma lucidum-derived polysacharide on human monocytoid dendritic cells pulsed with Der p 1 allergen. BMC Immunol. 2011;12:31.
186.Janeway CA Jr, Travers P, Walport M, et al. The components of the immune system. In: Immunobiology: The Immune System in Health and Disease. 5th edition. New York: Garland Sciences; 2001.
187.Jayasooriya RG, Kang SH, et al. Apigenin decreases cell viability and telomerase activity in human leukemia cell lines. Food Chem Toxicol. 2012 Aug;50(8):2605-11.
188.Jensen CD, Block G, Buffler P, Ma X, Selvin S, Month S. Maternal dietary risk factors in childhood acute lymphoblastic leukemia (United States). Cancer causes & control: CCC. Aug 2004;15(6):559-570.
189.Jeurink PV, Noguera CL, Savelkoul HF, Wichers HJ. Immunomodulatory capacity of fungal proteins on the cytokine production of human peripheral blood mononuclear cells. Int Immunopharmacol. 2008 Aug;8(8):1124-33.
190.Jho DH, Cole SM, et al. Role of omega-3 fatty acid supplementation in inflammation and malignancy. Integr Cancer Ther. 2004 Jun;3(2):98-111.
191.Ji Z, Tang Q, Zhang J, Yang Y, Liu Y, Pan YJ. Immunomodulation of bone marrow macrophages by GLIS, a proteoglycan fraction from Lingzhi or Reishi medicinal mushroom Ganoderma lucidium (W.Curt.:Fr.) P. Karst. Int J Med Mushrooms. 2011;13(5):441-8.
192.Jia XH, Yin BH, Li JC. [Effect of astragalus injection on U937 leukemia cells proliferation and apoptosis and relevant molecular mechanisms]. Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics. Dec 2013;15(12):1128-1133.
193.Joe AK, Liu H, et al. Resveratrol induces growth inhibition, S-phase arrest, apoptosis, and changes in biomarker expression in several human cancer cell lines. Clin Cancer Res. 2002 Mar;8(3):893-903.
194.Joh D, Park BJ, Lim YJ. Radiation-induced glioblastoma multiforme in a remitted acute lymphocytic leukemia patient. J Korean Neurosurg Soc. 2011 Sep;50(3):235-9.
195.John EM, Savitz DA, Sandler DP. Prenatal exposure to parents' smoking and childhood cancer. Am J Epidemiol. 1991 Jan 15;133(2):123-32.
196.Johnson-Ansah H, Guilhot J, et al. Cancer. Tolerability and efficacy of pegylated interferon-α-2a in combination with imatinib for patients with chronic-phase chronic myeloid leukemia. 2013 Dec 15;119(24):4284-9.
197.Jonasch E, Haluska FG. Interferon in oncological practice: review of interferon biology, clinical applications, and toxicities. Oncologist. 2001;6(1):34-55.
198.Jones RR, Yu CL, Nuckols JR, Cerhan JR, Airola M, Ross JA, . . . Ward MH. Farm residence and lymphohematopoietic cancers in the Iowa Womens Health Study. Environmental research. Jul 16 2014;133c:353-361.
199.Joseph S, Sabulal B, et al. Antitumor and anti-inflammatory activities of polysaccharides isolated from Ganoderma lucidum. Acta Pharm. 2011 Sep 1;61(3):335-42.
200.Kadan-Lottick NS, Kawashima T, et al. The risk of cancer in twins: a report from the childhood cancer survivor study. Pediatr Blood Cancer. 2006 Apr;46(4):476-81.
201.Kamil N, Kamil S, Ahmed SP, Ashraf R, Khurram M, Ali MO. Toxic effects of multiple anticancer drugs on skin. Pakistan journal of pharmaceutical sciences. Jan 2010;23(1):7-14.
202.Kang JH, Song KH, et al. Ginsenoside Rp1 from Panax ginseng exhibits anti-cancer activity by down-regulating of the IGF-1R/Akt pathway in breast cancer cells. Plant Foods Hum Nutr. 2011;66(3):298-305.
203.Kantarjian HM, Keating MJ, et al. Treatment of advanced stages of Philadelphia chromosome-positive chronic myeloid leukemia with interferon-alpha and low-dose cytarabine. J Clin Oncol. 1992 May;10(5):772-8.
204.Kantarjian HM, Martinelli G, et al. Stage I of a phase 2 study assessing the efficacy, safety, and tolerability of barasertib (AZD1152) versus low-dose cytosine arabinoside in elderly patients with acute myeloid leukemia. Cancer. 2013 Jul 15;119(14):2611-9.
205.Kaplan HG, Malmgren JA, Atwood MK. Increased incidence of myelodysplastic syndrome and acute myeloid leukemia following breast cancer treatment with radiation alone or combined with chemotherapy: a registry cohort analysis 1990-2005. BMC cancer. 2011;11:260.
206.Karsunky H, Merad M, Cozzio A, Weissman IL, Manz MG. Flt3 ligand regulates dendritic cell development from Flt3+ lymphoid and myeloid-committed progenitors to Flt3+ dendritic cells in vivo. The Journal of experimental medicine. Jul 21 2003;198(2):305-313.
207.Kasim K, Levallois P, Abdous B, Auger P, Johnson KC. Lifestyle factors and the risk of adult leukemia in Canada. Cancer causes & control: CCC. Jun 2005;16(5):489-500.
208.Katagiri S, Tauchi T, et al. Combination of ponatinib with Hedgehog antagonist vismodegib for therapy-resistant BCR-ABL1-positive leukemia. Clin Cancer Res. 2013 Mar 15;19(6):1422-32.
209.Kawada H, Kaneko M, et al. High concentrations of L-ascorbic acid specifically inhibit the growth of human leukemic cells via downregulation of HIF-1α transcription. PLoS One. 2013 Apr 23;8(4):e62717.
210.Kawahara T, Kawaguchi-Ihara N, et al. Cyclopamine and quercetin suppress the growth of leukemia and lymphoma cells. Anticancer Res. 2009 Nov;29(11):4629-32.
211.Kawasaki ES, Clark SS, et al. Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro. Proc Natl Acad Sci U S A. 1988 Aug;85(15):5698-702.
212.Kelly KR, Shea TC, et al. Phase I study of MLN8237-investigational Aurora A kinase inhibitor-in relapsed/refractory multiple myeloma, Non-Hodgkin lymphoma and chronic lymphocytic leukemia. Invest New Drugs. 2013 Dec 20.
213.Kennel KA, Drake MT. Vitamin D in the cancer patient. Current opinion in supportive and palliative care. Sep 2013;7(3):272-277.
214.Kharfan-Dabaja MA, Moukalled N, Reljic T, El-Asmar J, Kumar A. Reduced intensity is preferred over myeloablative conditioning allogeneic HCT in chronic lymphocytic leukemia whenever indicated: A systematic review/meta-analysis. Hematol Oncol Stem Cell Ther. Jun 2018;11(2):53-64. doi:10.1016/j.hemonc.2017.11.001
215.Khimani F, Dutta M, Faramand R, et al. Impact of Total Body Irradiation-Based Myeloablative Conditioning Regimens in Patients with Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: Systematic Review and Meta-Analysis. Transplant Cell Ther. Jul 2021;27(7):620.e1-620.e9. doi:10.1016/j.jtct.2021.03.026
216.Kilani-Jaziri S, Frachet V, et al. Flavones inhibit the proliferation of human tumor cancer cell lines by inducing apoptosis. Drug Chem Toxicol. 2012 Jan;35(1):1-10.
217.Kim HI, Huang H, Cheepala S, Huang S, Chung J. Curcumin inhibition of integrin (alpha6beta4)-dependent breast cancer cell motility and invasion. Cancer prevention research (Philadelphia, Pa.). Oct 2008;1(5):385-391.
218.Kim M, Mirandola L, et al. Review Application of vitamin D and derivatives in hematological malignancies. Cancer Lett. 2012 Jun 1; 319(1):8-22.
219.Kim SH, Cho SS, et al. Enhancement of 1,25-dihydroxyvitamin D3- and all-trans retinoic acid-induced HL-60 leukemia cell differentiation by Panax ginseng. Biosci Biotechnol Biochem. 2009 May;73(5):1048-53.
220.Kim YS, Farrar W, et al. Cancer stem cells: potential target for bioactive food components. J Nutr Biochem. 2012 Jul;23(7):691-8.
221.Knapp HR. Reduced allergen-induced nasal congestion and leukotriene synthesis with an orally active 5-lipoxygenase inhibitor. N Engl J Med. 1990 Dec 20;323(25):1745-8.
222.Knusli C, Walter M. [Update - health risks induced by ionizing radiation from diagnostic imaging]. Therapeutische Umschau. Revue therapeutique. Dec 2013;70(12):746-751.
223.Korte JE, Hertz-Picciotto I, et al. The contribution of benzene to smoking-induced leukemia. Environ Health Perspect. 2000 Apr;108(4):333-9.
224.Kottaridis PD, Gale RE, et al. The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials. Blood. 2001 Sep 15;98(6):1752-9.
225.Kuo YC, Yu CL, et al. A population-based, case-control study of green tea consumption and leukemia risk in southwestern Taiwan. Cancer Causes Control. 2009 Feb;20(1):57-65.
226.Kwan ML, Jensen CD, Block G, Hudes ML, Chu LW, Buffler PA. Maternal diet and risk of childhood acute lymphoblastic leukemia. Public health reports (Washington, D.C. : 1974). Jul-Aug 2009;124(4):503-514.
227.Kweon SH, Song JH, Kim TS. Resveratrol-mediated reversal of doxorubicin resistance in acute myeloid leukemia cells via downregulation of MRP1 expression. Biochem Biophys Res Commun. 2010 Apr 23;395(1):104-10.
228.Lai CY, Hung JT, Lin HH, et al. Immunomodulatory and adjuvant activities of a polysaccharide extract of Ganoderma lucidum in vivo and in vitro. Vaccine. 2010 Jul 12;28(31):4945-54.
229.Lancet JE, Gojo I, et al. Phase I study of the heat shock protein 90 inhibitor alvespimycin (KOS-1022, 17-DMAG) administered intravenously twice weekly to patients with acute myeloid leukemia. Leukemia. 2010 Apr;24(4):699-705.
230.Lee HJ, Muindi JR, et al. Low 25(OH) vitamin D3 levels are associated with adverse outcome in newly diagnosed, intensively treated adult acute myeloid leukemia. Cancer. 2014 Feb 15;120(4):521-9.
231.Lee JM, Hah JO, Kim HS. The effect of red ginseng extract on inflammatory cytokines after chemotherapy in children. J Ginseng Res. 2012 Oct;36(4):383-90.
232.Lee LT, Huang YT, Hwang JJ, Lee PP, Ke FC, Nair MP, . . . Lee MT. Blockade of the epidermal growth factor receptor tyrosine kinase activity by quercetin and luteolin leads to growth inhibition and apoptosis of pancreatic tumor cells. Anticancer research. May-Jun 2002;22(3):1615-1627.
233.Lee MK, Hung TM, Cuong TD, Na M, Kim JC, Kim EJ, . . . Min BS. Ergosta-7,22-diene-2beta,3alpha,9alpha-triol from the fruit bodies of Ganoderma lucidum induces apoptosis in human myelocytic HL-60 cells. Phytotherapy research: PTR. Nov 2011;25(11):1579-1585.
234.Lee R, Kim YJ, et al. The selective effect of genistein on the toxicity of bleomycin in normal lymphocytes and HL-60 cells. Toxicology. 2004 Feb 15;195(2-3):87-95.
235.Lee SJ, Ko WG, et al. Induction of apoptosis by a novel intestinal metabolite of ginseng saponin via cytochrome c-mediated activation of caspase-3 protease. Biochem Pharmacol. 2000 Sep 1;60(5):677-85.
236.Lee SK, Zhang W, Sanderson BJ. Selective growth inhibition of human leukemia and human lymphoblastoid cells by resveratrol via cell cycle arrest and apoptosis induction. J Agric Food Chem. 2008 Aug 27;56(16):7572-7.
237.Lee WJ, Chen YR, Tseng TH. Quercetin induces FasL-related apoptosis, in part, through promotion of histone H3 acetylation in human leukemia HL-60 cells. Oncol Rep. 2011 Feb;25(2):583-91.
238.Lehtinen M, Koskela P, et al. Maternal herpesvirus infections and risk of acute lymphoblastic leukemia in the offspring. Am J Epidemiol. 2003 158(3):207-213.
239.Leone G, Fianchi L, et al. Incidence and susceptibility to therapy-related myeloid neoplasms. Chem Biol Interact. 2010 Mar 19;184(1-2):39-45.
240.Leone G, Pagano L, et al. Therapy-related leukemia and myelodysplasia: susceptibility and incidence. Haematologica. 2007 Oct;92(10):1389-98.
241.Li K, Jing Y, Yang C, Liu S, Zhao Y, He X, . . . Li G. Increased leukemia-associated gene expression in benzene-exposed workers. Scientific reports. 2014;4:5369.
242.Li N, Li XM, Xu L, Sun WJ, Cheng XG, Tian W. Comparison of QCT and DXA: Osteoporosis Detection Rates in Postmenopausal Women. International journal of endocrinology. 2013;2013:895474.
243.Liersch R, Muller-Tidow C, Berdel WE, Krug U. Prognostic factors for acute myeloid leukaemia in adults--biological significance and clinical use. British journal of haematology. Apr 2014;165(1):17-38.
244.Lin LC, Yeh CT, et al. Sulforaphane potentiates the efficacy of imatinib against chronic leukemia cancer stem cells through enhanced abrogation of Wnt/β-catenin function. J Agric Food Chem. 2012 Jul 18;60(28):7031-9.
245.Lissoni P, Bolis S, et al. A phase II study of neuroimmunotherapy with subcutaneous low-dose IL-2 plus the pineal hormone melatonin in untreatable advanced hematologic malignancies. Anticancer Res. 2000 May Jun;20(3B):2103-5.
246.Liu CY, Hsu YH, Wu MT, Pan PC, Ho CK, Su L, . . . Christiani DC. Cured meat, vegetables, and bean-curd foods in relation to childhood acute leukemia risk: a population based case-control study. BMC cancer. 2009;9:15.
247.Liu LM, Zhang LS. [Effect of astragalus polysaccharide on the function and maturation of plasmacytoid dendritic cells from chronic myelogenous leukemia before and after treatment.]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi. Nov 2010;31(11):740-743.
248.Liu Y, Bao EN, Zhong WW, Lu XC, Zhu HL. [Efficacy and safety analysis of interferon combined with imatinib in treating chronic myeloid leukemia]. Zhongguo shi yan xue ye xue za zhi / Zhongguo bing li sheng li xue hui = Journal of experimental hematology / Chinese Association of Pathophysiology. Mar 2014;22(2):304-309.
249.LLS. Leukemia & Lymphoma Society. Acute Lymphoblastic Leukemia. Available at: http://www.lls.org/content/nationalcontent/resourcecenter/freeeducationmaterials/leukemia/pdf/all.pdf. 2/2014a. Accessed 5/13/2014.
250.LLS. Leukemia & Lymphoma Society. Acute Myeloid Leukemia. Available at: http://www.lls.org/content/nationalcontent/resourcecenter/freeeducationmaterials/leukemia/pdf/aml.pdf. 12/2011a. Accessed 5/13/2014.
251.LLS. Leukemia & Lymphoma Society. Chronic Lymphocytic Leukemia. Available at: http://www.lls.org/content/nationalcontent/resourcecenter/freeeducationmaterials/leukemia/pdf/cll.pdf. 12/2011b. Accessed 5/13/2014.
252.LLS. Leukemia & Lymphoma Society. Chronic Myeloid Leukemia. Available at: http://www.lls.org/content/nationalcontent/resourcecenter/freeeducationmaterials/leukemia/pdf/cml.pdf. 5/2012a. Accessed 5/13/2014.
253.LLS. Leukemia & Lymphoma Society. Disease Information & Support page. Leukemia: What Is Leukemia? Available at: http://www.lls.org/#/diseaseinformation/leukemia/. Accessed 8/18/2014b.
254.LLS. Leukemia & Lymphoma Society. Disease Information and Support. Diagnosis: Lab Tests to Confirm a Diagnosis. Available at: http://www.lls.org/diseaseinformation/leukemia/acutemyeloidleukemia/diagnosis/. 2012c. Accessed 8/7/2014.
255.LLS. Leukemia & Lymphoma Society. Understanding Leukemia. Available at: http://www.lls.org/content/nationalcontent/resourcecenter/freeeducationmaterials/leukemia/pdf/understandingleukemia.pdf. 8/2012b. Accessed 5/13/2014.
256.LLS. Leukemia and Lymphoma Society. About Childhood ALL. Available at: http://www.lls.org/#/diseaseinformation/leukemia/acutelymphoblasticleukemia/childhoodall/. 2011c. Accessed 08/11/2014.
257.Lobato-Mendizábal E, Ruiz-Argüelles GJ, Marín-López A. Leukaemia and nutrition. I: Malnutrition is an adverse prognostic factor in the outcome of treatment of patients with standard-risk acute lymphoblastic leukaemia. Leuk Res. 1989;13(10):899-906.
258.Lo-Coco F, Avvisati G, Vignetti M, Thiede C, Orlando SM, Iacobelli S, . . . Platzbecker U. Retinoic acid and arsenic trioxide for acute promyelocytic leukemia. The New England journal of medicine. Jul 11 2013;369(2):111-121.
259.Löwenberg B, Muus P, et al. Phase 1/2 study to assess the safety, efficacy, and pharmacokinetics of barasertib (AZD1152) in patients with advanced acute myeloid leukemia. Blood. 2011 Dec 1;118(23):6030-6.
260.Lu H, Kyo E, Uesaka T, Katoh O, Watanabe H. Prevention of development of N,N’-dimethylhydrazine-induced colon tumors by a water-soluble extract from cultured medium of Ganoderma lucidum (Rei-shi) mycelia in male ICR mice. Int J Mol Med. 2002 Feb;9(2):113-7.
261.Lu H, Uesaka T, Katoh O, Kyo E, Watanabe H. Prevention of the development of preneoplastic lesions, aberrant crypt foci, by a water-soluble extract from cultured medium of Ganoderma lucidum (Rei-shi) mycelia in male F344 rats. Oncol Rep. 2001 Nov- Dec;8(6):1341-5.
262.Lu HF, Tung WL, et al. In vitro suppression of growth of murine WEHI-3 leukemia cells and in vivo promotion of phagocytosis in a leukemia mice model by indole-3-carbinol. J Agric Food Chem. 2012 Aug 8;60(31):7634-43.
263.Lund FE, Randall TD. Effector and regulatory B cells: modulators of CD4+ T cell immunity. Nature reviews. Immunology. Apr 2010;10(4):236-247.
264.Ly BT, Chi HT, et al. Inhibition of FLT3 expression by green tea catechins in FLT3 mutated-AML cells. PLoS One. 2013 Jun 20;8(6):e66378.
265.Ma X, Park Y, Mayne ST, Wang R, Sinha R, Hollenbeck AR, . . . Cross AJ. Diet, lifestyle, and acute myeloid leukemia in the NIH-AARP cohort. American journal of epidemiology. Feb 1 2010;171(3):312-322.
266.Machijima Y, Ishikawa C, et al. Anti-adult T-cell leukemia/lymphoma effects of indole-3-carbinol. Retrovirology. 2009 Jan 16;6:7.
267.Magana Torres MT, Gonzalez Garcia JR. Comment on 'Childhood leukaemia close to high-voltage power lines--the Geocap study, 2002-2007'--odds ratio and confidence interval. British journal of cancer. Sep 3 2013;109(5):1384-1385.
268.Maslak P. First Consult. Acute myelogenous leukemia. Available at: www.clinicalkey.com. Last updated 9/6/2012. Accessed 4/22/2014.
269.Mathews JD, Forsythe AV, Brady Z, Butler MW, Goergen SK, Byrnes GB, . . . Darby SC. Cancer risk in 680,000 people exposed to computed tomography scans in childhood or adolescence: data linkage study of 11 million Australians. BMJ (Clinical research ed.). 2013;346:f2360.
270.Mauch P, Constine L, Greenberger J, Knospe W, Sullivan J, Liesveld JL, Deeg HJ. Hematopoietic stem cell compartment: acute and late effects of radiation therapy and chemotherapy. International journal of radiation oncology, biology, physics. Mar 30 1995;31(5):1319-1339.
271.Mauro MJ, Druker BJ. STI571: targeting BCR-ABL as therapy for CML. The oncologist. 2001;6(3):233-238.
272.Medeiros BC, Othus M, et al. Prognostic impact of monosomal karyotype in young adult and elderly acute myeloid leukemia: the Southwest Oncology Group (SWOG) experience. Blood. 2010 Sep 30;116(13):2224-8.
273.Meijerink JP, den Boer ML, Pieters R. New genetic abnormalities and treatment response in acute lymphoblastic leukemia. Seminars in hematology. Jan 2009;46(1):16-23.
274.Memorial Sloan Kettering Cancer Center. Allogenic Transplantation. Overview. Accessed 1/13/2022, https://www.mskcc.org/cancer-care/diagnosis-treatment/cancer-treatments/blood-stem-cell-transplantation/allogeneic
275.Miglioretti DL, Johnson E, Williams A, Greenlee RT, Weinmann S, Solberg LI, . . . Smith-Bindman R. The use of computed tomography in pediatrics and the associated radiation exposure and estimated cancer risk. JAMA pediatrics. Aug 1 2013;167(8):700-707.
276.Miron T, Wilchek M, et al. Allicin inhibits cell growth and induces apoptosis through the mitochondrial pathway in HL60 and U937 cells. J Nutr Biochem. 2008 Aug; 19(8):524-35.
277.Monasterio A, Urdaci MC, et al. Flavonoids induce apoptosis in human leukemia U937 cells through caspase- and caspase-calpain-dependent pathways. Nutr Cancer. 2004;50(1):90-100.
278.Morton LM, Dores GM, Tucker MA, Kim CJ, Onel K, Gilbert ES, . . . Curtis RE. Evolving risk of therapy-related acute myeloid leukemia following cancer chemotherapy among adults in the United States, 1975-2008. Blood. Apr 11 2013;121(15):2996-3004.
279.Mughal TI, Ejaz AA, et al. An integrated clinical approach for the identification, prevention, and treatment of tumor lysis syndrome. Cancer Treat Rev. 2010 Apr;36(2):164-76.
280.Mukherjee Nee Chakraborty S, Ghosh U, et al. Curcumin-induced apoptosis in human leukemia cell HL-60 is associated with inhibition of telomerase activity. Mol Cell Biochem. 2007 Mar;297(1-2):31-9.
281.Müller CI, Kumagai T, et al. Ganoderma lucidum causes apoptosis in leukemia, lymphoma and multiple myeloma cells. Leuk Res. 2006 Jul;30(7):841-8.
282.Murphy RA, Mourtzakis M, Chu QS, Baracos VE, Reiman T, Mazurak VC. Supplementation with fish oil increases first-line chemotherapy efficacy in patients with advanced nonsmall cell lung cancer. Cancer. Aug 15 2011;117(16):3774-3780.
283.Musselman JR, Blair CK, et al. Risk of adult acute and chronic myeloid leukemia with cigarette smoking and cessation. Cancer Epidemiol. 2013 Aug;37(4):410-6.
284.Nagao R, Ashihara E, Kimura S, Strovel JW, Yao H, Takeuchi M, . . . Maekawa T. Growth inhibition of imatinib-resistant CML cells with the T315I mutation and hypoxia-adaptation by AV65--a novel Wnt/beta-catenin signaling inhibitor. Cancer letters. Dec 15 2011;312(1):91-100.
285.Nakazato T, Ito K, et al. Catechin, a green tea component, rapidly induces apoptosis of myeloid leukemic cells via modulation of reactive oxygen species production in vitroand inhibits tumor growth in vivo. Haematologica. 2005 Mar;90(3):317-25.
286.Nature Education. Library page. Cell Differentiation and Tissue. Available at: http://www.nature.com/scitable/topicpage/cell-differentiation-and-tissue-14046412. Copyright 2014. Accessed 9/23/2014.
287.Naz A, N Qureshi R, et al. Vitamin D levels in patients of acute leukemia before and after remission-induction therapy. Pak J Med Sci. 2013 Jan;29(1):10-4.
288.NCI. National Cancer Institute. Cancer Topics page. Understanding Cancer Prognosis. Available at: http://www.cancer.gov/cancertopics/factsheet/Support/prognosis-stats. 5/11/2012. Accessed 9/25/2014.
289.NCI. National Cancer Institute. NCI Dictionary of Cancer Terms page. Differentiation. Available at: http://www.cancer.gov/dictionary?cdrid=46445. Accessed 9/23/2014c.
290.NCI. National Cancer Institute. Cancer Topics page. FDA Approval for Ponatinib Hydrochloride. Available at: http://www.cancer.gov/cancertopics/druginfo/fda-ponatinibhydrochloride. Last updated 3/12/2014b. Accessed 7/17/2014.
291.NCI. National Cancer Institute. SEER: Surveillance, Epidemiology, and End Results Program. Cancer Statistics page. SEER Stat Facts: Leukemia. Available at: http://seer.cancer.gov/statfacts/html/leuks.html. Accessed 7/21/2014a.
292.Negrin RS. Early complications of hematopoietic cell transplantation. Updated 7/7/2020. Accessed 1/13/2022, https://www.uptodate.com/contents/early-complications-of-hematopoietic-cell-transplantation
293.Neyestani TR, Fereydouni Z, Hejazi S, Salehi-Nasab F, Nateghifard F, Maddah M, Karandish M. Vitamin C status in Iranian children with acute lymphoblastic leukemia: evidence for increased utilization. Journal of pediatric gastroenterology and nutrition. Jul 2007;45(1):141-144.
294.Ng KP, Hillmer AM, Chuah CT, Juan WC, Ko TK, Teo AS, . . . Ong ST. A common BIM deletion polymorphism mediates intrinsic resistance and inferior responses to tyrosine kinase inhibitors in cancer. Nature medicine. Apr 2012;18(4):521-528.
295.Nguyen HT, Song GY, et al. Dammarane-type saponins from the flower buds of Panax ginseng and their effects on human leukemia cells. Bioorg Med Chem Lett. 2010 Jan 1;20(1):309-14.
296.Nian H, Delage B, et al. Modulation of histone deacetylase activity by dietary isothiocyanates and allyl sulfides: studies with sulforaphane and garlic organosulfur compounds. Environ Mol Mutagen. 2009 Apr;50(3):213-21.
297.Ntziachristos P, Mullenders J, et al. Mechanisms of epigenetic regulation of leukemia onset and progression. Adv Immunol. 2013;117:1-38.
298.O'Donnell MR, Abboud CN, Altman J, Appelbaum FR, Arber DA, Attar E, . . . Gregory KM. Acute myeloid leukemia. Journal of the National Comprehensive Cancer Network : JNCCN. Aug 2012;10(8):984-1021.
299.Ohno S, Ohno Y, Suzuki N, Soma G, Inoue M. High-dose vitamin C (ascorbic acid) therapy in the treatment of patients with advanced cancer. Anticancer research. Mar 2009;29(3):809-815.
300.Oka S, Tanaka S, Yoshida S, et al. A water-soluble extract from culture medium of Ganoderma lucidum mycelia suppresses the development of colorectal adenomas. Hiroshima J Med Sci. 2010 Mar;59(1):1-6.
301.O'Mahony D, Bishop MR. Monoclonal antibody therapy. Front Biosci. 2006 May 1;11:1620-35.
302.Omoregie SN, Omoruyi FO, et al. Antiproliferative activities of lesser galangal (Alpinia officinarum Hance Jam1), turmeric (Curcuma longa L.), and ginger (Zingiber officinale Rosc.) against acute monocytic leukemia. J Med Food. 2013 Jul;16(7):647-55.
303.Ooi VE, Liu F. Immunomodulation and anti-cancer activity of polysaccharide-protein complexes. Curr Med Chem. 2000 Jul;7(7):715-29.
304.Ozer H, George SL, et al. Prolonged subcutaneous administration of recombinant alpha 2b interferon in patients with previously untreated Philadelphia chromosome-positive chronic-phase chronic myeloid leukemia: effect on remission duration and survival: Cancer and Leukemia Group B study 8583. Blood 1993;82:2975-2984.
305.Pae HO, Jeong SO, et al. Curcumin induces pro-apoptotic endoplasmic reticulum stress in human leukemia HL-60 cells. Biochem Biophys Res Commun. 2007 Feb 23;353(4):1040-5.
306.Paneesha S. ePocrates. Chronic lymphocytic leukemia. Available at: https://online.epocrates.com/noFrame/showPage.do?method=diseases&MonographId=275. Last updated 1/30/2014. Accessed 4/17/2014.
307.Panizo C, Patino A, Lecumberri R, Calasanz MJ, Odero MD, Bendandi M, Rocha E. Secondary myelodysplastic syndrome after treatment for promyelocytic leukemia: clinical and genetic features of two cases. Cancer genetics and cytogenetics. Jun 2003;143(2):178-181.
308.Park S. The effects of high concentrations of vitamin C on cancer cells. Nutrients. Sep 2013;5(9):3496-3505.
309.Passegue E, Ernst P. IFN-alpha wakes up sleeping hematopoietic stem cells. Nature medicine. Jun 2009;15(6):612-613.
310.Paustenbach DJ, Price PS, Ollison W, Blank C, Jernigan JD, Bass RD, Peterson HD. Reevaluation of benzene exposure for the Pliofilm (rubberworker) cohort (1936-1976). Journal of toxicology and environmental health. Jul 1992;36(3):177-231.
311.Pawarode A, Baer MR. Rare Leukemias. Textbook of Uncommon Cancer: John Wiley & Sons, Ltd; 2006:543-554.
312.Pearce MS, Salotti JA, Little MP, McHugh K, Lee C, Kim KP, . . . Berrington de Gonzalez A. Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study. Lancet. Aug 4 2012;380(9840):499-505.
313.Pearson RL, Wachtel H, Ebi KL. Distance-weighted traffic density in proximity to a home is a risk factor for leukemia and other childhood cancers. Journal of the Air & Waste Management Association (1995). Feb 2000;50(2):175-180.
314.Pedersen C, Raaschou-Nielsen O, Rod NH, Frei P, Poulsen AH, Johansen C, Schuz J. Distance from residence to power line and risk of childhood leukemia: a population-based case-control study in Denmark. Cancer causes & control: CCC. Feb 2014;25(2):171-177.
315.Pedersen-Bjergaard J, Andersen MK, Christiansen DH. Therapy-related acute myeloid leukemia and myelodysplasia after high-dose chemotherapy and autologous stem cell transplantation. Blood. 2000 Jun 1;95(11):3273-9.
316.Peggs KS. Chimeric antigen receptors: a costimulatory boost promotes immunological memory to B-cell malignancies. Expert Rev Anticancer Ther. 2011 Nov;11(11):1667-70.
317.Perkins SM, Dewees T, et al. Risk of subsequent malignancies in survivors of childhood leukemia. J Cancer Surviv. 2013 Dec;7(4):544-50.
318.Perry AK, Chen G, Zheng D, Tang H, Cheng G. The host type I interferon response to viral and bacterial infections. Cell research. Jun 2005;15(6):407-422.
319.Petridou E, Ntouvelis E, Dessypris N, Terzidis A, Trichopoulos D. Maternal diet and acute lymphoblastic leukemia in young children. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Aug 2005;14(8):1935-1939.
320.Pfeffer LM. Biologic activities of natural and synthetic type I interferons. Seminars in oncology. Jun 1997;24(3 Suppl 9):S9-63-s69-69.
321.Philchenkov AA, Zavelevich MP, et al. Apoptosis and content of mobile lipid domains in human leukemia K-562 cells induced to differentiate by quercetin or dimethyl sulfoxide. Ukr Biokhim Zh. 2010 Mar-Apr;82(2):104-10.
322.Piemonti L, Monti P, Sironi M, Fraticelli P, Leone BE, Dal Cin E, . . . Di Carlo V. Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells. Journal of immunology (Baltimore, Md. : 1950). May 1 2000;164(9):4443-4451.
323.Podhorecka M, Halicka D, et al. Resveratrol increases rate of apoptosis caused by purine analogues in malignant lymphocytes of chronic lymphocytic leukemia. Ann Hematol. 2011 Feb;90(2):173-83.
324.Ponvilawan B, Kungwankiattichai S, Charoenngam N, Owattanapanich W. Is stem cell transplantation still needed for adult Philadelphia chromosome-positive acute lymphoblastic leukemia receiving tyrosine kinase inhibitors therapy?: A systematic review and meta-analysis. PLoS One. 2021;16(6):e0253896. doi:10.1371/journal.pone.0253896
325.Poole CA, Byers T, et al. Influence of a family history of cancer within and across multiple sites on patterns of cancer mortality risk for women. Am J Epidemiol. 1999 Mar 1;149(5):454-62.
326.Porter DL, Levine BL, et al. Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia. N Engl J Med. 2011 Aug 25;365(8):725-33.
327.Pottern LM, Linet M, et al. Familial cancers associated with subtypes of leukemia and non-Hodgkin's lymphoma. Leuk Res. 1991;15(5):305-14.
328.Pray L. Gleevac: the Breakthrough in Cancer Treatment. Nature Education. 2008;1(1):37
329.Preston DL, Kusumi S, et al. Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950-1987. Radiat Res. 1994 Feb;137(2 Suppl):S68-97.
330.Pui CH, Mullighan CG, Evans WE, Relling MV. Pediatric acute lymphoblastic leukemia: where are we going and how do we get there? Blood. Aug 9 2012;120(6):1165-1174.
331.Quesenberry PJ, Butera JN. An interesting fishing expedition. Cancer Biol Ther. 2009 Feb;8(4):338-9.
332.Quoc Trung L, Espinoza JL, Takami A, Nakao S. Resveratrol induces cell cycle arrest and apoptosis in malignant NK cells via JAK2/STAT3 pathway inhibition. PloS one. 2013;8(1):e55183.
333.Raj K, Mehta P. ePocrates. Acute myelogenous leukemia. Available at: https://online.epocrates.com/noFrame/showPage.do?method=diseases&MonographId=274. Last updated 8/9/2013. Accessed 4/17/2014.
334.Rao A. ePocrates. Acute lymphocytic leukemia. Available at: https://online.epocrates.com/noFrame/showPage.do?method=diseases&MonographId=273. Last updated 8/30/2013. Accessed 4/17/2014.
335.Rao J, Xu DR, et al. Curcumin reduces expression of Bcl-2, leading to apoptosis in daunorubicin-insensitive CD34+ acute myeloid leukemia cell lines and primary sorted CD34+ acute myeloid leukemia cells. J Transl Med. 2011 May 19;9:71.
336.Ravandi F, Estey EH, et al. Gemtuzumab ozogamicin: time to resurrect? J Clin Oncol. 2012;30(32):3921–3923.
337.Ravandi F, Estrov Z. Eradication of leukemia stem cells as a new goal of therapy in leukemia. Clinical cancer research: an official journal of the American Association for Cancer Research. Jan 15 2006;12(2):340-344.
338.Ravindran J, Prasad S, et al. Curcumin and cancer cells: how many ways can curry kill tumor cells selectively? AAPS J. 2009 Sep;11(3):495-510.
339.Raynal NJ, Momparler L, et al. Antileukemic activity of genistein, a major isoflavone present in soy products. J Nat Prod. 2008 Jan;71(1):3-7.
340.Reis-Sobreiro M, Gajate C, Mollinedo F. Involvement of mitochondria and recruitment of Fas/CD95 signaling in lipid rafts in resveratrol-mediated antimyeloma and antileukemia actions. Oncogene. 2009; 28:3221–34.
341.Ricart AD. Antibody-drug conjugates of calicheamicin derivative: gemtuzumab ozogamicin and inotuzumab ozogamicin. Clin Cancer Res. 2011 Oct 15;17(20):6417-27.
342.Robertson MJ, Tantravahi R, Griffin JD, et al. Hematologic remission and cytogenetic improvement after treatment of stable-phase chronic myeloid leukemia with continuous infusion of low-dose cytarabine. Am J Hematol. 1993 Jun;43(2):95-102.
343.Roomi MW, House D, et al. Growth suppression of malignant leukemia cell line in vitroby ascorbic acid (vitamin C) and its derivatives. Vitamin C: Cancer Lett. 1998 Jan 9;122(1-2):93-9.
344.Roomi MW, Roomi NW, et al. Nutrient mixture inhibits in vitroand in vivogrowth of human acute promyelocytic leukemia HL-60 cells. Exp Oncol. 2011 Dec;33(4):212-5.
345.Roosli M. [Health effects of electromagnetic fields]. Therapeutische Umschau. Revue therapeutique. Dec 2013;70(12):733-738.
346.Ross JA, Spector LG, et al. Epidemiology of leukemia in children with Down syndrome. Pediatr Blood Cancer. 2005 Jan;44(1):8-12.
347.Ruela-de-Sousa RR, Fuhler GM, et al. Cytotoxicity of apigenin on leukemia cell lines: implications for prevention and therapy. Cell Death Dis. 2010;1:e19.
348.Russo M, Spagnuolo C, Volpe S, Mupo A, Tedesco I, Russo GL. Quercetin induced apoptosis in association with death receptors and fludarabine in cells isolated from chronic lymphocytic leukaemia patients. British journal of cancer. Aug 24 2010;103(5):642-648.
349.Russo M, Spagnuolo C, Volpe S, Tedesco I, Bilotto S, Russo GL. ABT-737 resistance in B-cells isolated from chronic lymphocytic leukemia patients and leukemia cell lines is overcome by the pleiotropic kinase inhibitor quercetin through Mcl-1 down-regulation. Biochemical pharmacology. Apr 1 2013;85(7):927-936.
350.Saba HI. Decitabine in the treatment of myelodysplastic syndromes. Therapeutics and clinical risk management. Oct 2007;3(5):807-817.
351.Sadrzadeh H, Abtahi SM, Fathi AT. Infectious pathogens and hematologic malignancy. Discov Med. 2012 Dec;14(79):421-33.
352.Sánchez Y, Amrán D, et al. Genistein selectively potentiates arsenic trioxide-induced apoptosis in human leukemia cells via reactive oxygen species generation and activation of reactive oxygen species-inducible protein kinases (p38-MAPK, AMPK). Int J Cancer. 2008 Sep 1;123(5):1205-14.
353.Sánchez Y, Simón GP, et al. Curcumin stimulates reactive oxygen species production and potentiates apoptosis induction by the antitumor drugs arsenic trioxide and lonidamine in human myeloid leukemia cell lines. J Pharmacol Exp Ther. 2010 Oct;335(1):114-23.
354.Santoro R, Marani M, et al. Melatonin triggers p53Ser phosphorylation and prevents DNA damage accumulation. Oncogene. 2012 Jun 14;31(24):2931-42.
355.Sanz MA, Montesinos P, et al. Risk-adapted treatment of acute promyelocytic leukemia with all-trans retinoic acid and anthracycline monochemotherapy: long-term outcome of the LPA 99 multicenter study by the PETHEMA Group. Blood. 2008 Oct 15;112(8):3130-4.
356.Satou Y, Matsuoka M. Virological and immunological mechanisms in the pathogenesis of human T-cell leukemia virus type 1. Rev Med Virol. 2013 Sep;23(5):269-80.
357.Savitz DA, Andrews KW. Review of epidemiologic evidence on benzene and lymphatic and hematopoietic cancers. Am J Ind Med. 1997 Mar;31(3):287-95.
358.Schiffer CA SR. Complications. In: Kufe DW PR, Weichselbaum RR, et al., editors. , ed. Holland-Frei Cancer Medicine, 6th Ed. Hamilton Ontario Canada: BC Decker; 2003.
359.Schlenk RF, Fröhling S, et al. Phase III study of all-trans retinoic acid in previously untreated patients 61 years or older with acute myeloid leukemia. Leukemia. 2004 Nov;18(11):1798-803.
360.Schwilk E, Zhang L, Smith MT, Smith AH, Steinmaus C. Formaldehyde and leukemia: an updated meta-analysis and evaluation of bias. Journal of occupational and environmental medicine / American College of Occupational and Environmental Medicine. Sep 2010;52(9):878-886.
361.Scott AM, Wolchok JD, Old LJ. Antibody therapy of cancer. Nature reviews. Cancer. Apr 2012;12(4):278-287.
362.Scrimshaw NS. INCAP studies of nutrition and infection. Food and nutrition bulletin. Mar 2010;31(1):54-67.
363.Sekeres M, Sisson S, Kuter DJ, Rao D. First Consult. Myelodysplastic syndromes. Available at: www.clinicalkey.com. Last updated 9/1/2011. Accessed 5/15/2014.
364.Sekeres MA, Elson P, Kalaycio ME, Advani AS, Copelan EA, Faderl S, . . . Estey E. Time from diagnosis to treatment initiation predicts survival in younger, but not older, acute myeloid leukemia patients. Blood. Jan 1 2009;113(1):28-36.
365.Sermage-Faure C, Demoury C, Rudant J, Goujon-Bellec S, Guyot-Goubin A, Deschamps F, . . . Clavel J. Childhood leukaemia close to high-voltage power lines--the Geocap study, 2002-2007. British journal of cancer. May 14 2013;108(9):1899-1906.
366.Shih TY, Wu J, Muo CS, Kao CH. Association between leukaemia and X-ray in children: A nationwide study. Journal of paediatrics and child health. Aug 2014;50(8):615-618.
367.Shanafelt TD, Lee YK, et al. Clinical effects of oral green tea extracts in four patients with low grade B-cell malignancies. Leuk Res. 2006 Jun;30(6):707-12.
368.Shen ZX, Shi ZZ, et al. All-trans retinoic acid/As2O3 combination yields a high quality remission and survival in newly diagnosed acute promyelocytic leukemia. Proc Natl Acad Sci U S A. 2004 Apr 13;101(15):5328-35.
369.Shorey LE, Hagman AM, Williams DE, Ho E, Dashwood RH, Benninghoff AD. 3,3'-Diindolylmethane induces G1 arrest and apoptosis in human acute T-cell lymphoblastic leukemia cells. PloS one. 2012;7(4):e34975.
370.Sidaway GH. Powerline bioactivity - more than magnetism. SpringerPlus. 2013;2:454.
371.Siddikuzzaman, Guruvayoorappan C, Berlin Grace VM. All trans retinoic acid and cancer. Immunopharmacology and immunotoxicology. Jun 2011;33(2):241-249.
372.Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA: a cancer journal for clinicians. Jan-Feb 2014;64(1):9-29.
373.Siegel R, Naishadham D, et al. Cancer statistics, 2012. CA Cancer J Clin. 2012 Jan-Feb;62(1):10-29.
374.Siegel R, Naishadham D, et al. Cancer statistics, 2013. CA Cancer J Clin. 2013 Jan;63(1):11-30.
375.Siegel R, Ward E, et al. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 2011 Jul-Aug;61(4):212-36.
376.Simonsson B, Gedde-Dahl T, Markevarn B, Remes K, Stentoft J, Almqvist A, . . . Porkka K. Combination of pegylated IFN-alpha2b with imatinib increases molecular response rates in patients with low- or intermediate-risk chronic myeloid leukemia. Blood. Sep 22 2011;118(12):3228-3235.
377.Simonsson B, Hjorth-Hansen H, et al. Interferon alpha for treatment of chronic myeloid leukemia. Curr Drug Targets. 2011 Mar 1;12(3):420-8.
378.Sirois P, Borgeat P, Lauziere M, Dube L, Rubin P, Kesterson J. Effect of Zileuton (A-64077) on the 5-lipoxygenase activity of human whole blood ex vivo. Agents and actions. Sep 1991;34(1-2):117-120.
379.Slapak CA, Desforges JF, et al. Treatment of acute myeloid leukemia in the elderly with low-dose cytarabine, hydroxyurea, and calcitriol. Am J Hematol. 1992 Nov;41(3):178-83.
380.Sliva D. Ganoderma lucidum (Reishi) in cancer treatment. Integr Cancer Ther. 2003 Dec;2(4):358-64.
381.Small D. FLT3 mutations: biology and treatment. Hematology Am Soc Hematol Educ Program. 2006:178-84.
382.Smolewski P, et al. New Insights into Biology, Prognostic Factors, and Current Therapeutic Strategies in Chronic Lymphocytic Leukemia. ISRN Oncol. 2013 Aug 22;2013:740615.
383.Snyder R. Leukemia and benzene. International journal of environmental research and public health. Aug 2012;9(8):2875-2893.
384.Sohrabi MR, Tarjoman T, Abadi A, Yavari P. Living near overhead high voltage transmission power lines as a risk factor for childhood acute lymphoblastic leukemia: a case-control study. Asian Pacific journal of cancer prevention: APJCP. 2010;11(2):423-427.
385.Somervaille T. ePocrates. Chronic myelogenous leukemia. Available at: https://online.epocrates.com/noFrame/showPage.do?method=diseases&MonographId=276. Last updated 11/1/2013. Accessed 4/17/2014.
386.Spagnuolo C, Cerella C, Russo M, Chateauvieux S, Diederich M, Russo GL. Quercetin downregulates Mcl-1 by acting on mRNA stability and protein degradation. British journal of cancer. Jul 12 2011;105(2):221-230.
387.Spagnuolo C, Russo M, et al. Dietary polyphenols in cancer prevention: the example of the flavonoid quercetin in leukemia. Ann N Y Acad Sci. 2012 Jul;1259:95-103.

<!DOCTYPE html>
<html lang="es">
<head>
    <meta charset="UTF-8">  
    <link rel="icon" href="dc3.png" type="image/png">  
    <script src="https://cdnjs.cloudflare.com/ajax/libs/html2pdf.js/0.9.2/html2pdf.bundle.min.js"></script>
    <script src="https://cdn.jsdelivr.net/npm/sweetalert2@10"></script>
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>White Book</title>
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.0.0-beta3/css/all.min.css">
    <link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Montserrat:wght@700&display=swap">
    <!-- Estilos para dispositivos móviles -->
    <link rel="stylesheet" href="/commons/presentation/css/estilo_informeM.css?v=1.9&_=${new Date().getTime()}" media="only screen and (max-width: 768px)">
    <!-- Estilos para pantallas de PC -->
    <link rel="stylesheet" href="/commons/presentation/css/estilo_informeM.css?v=1.9&_=${new Date().getTime()}" media="only screen and (min-width: 769px)">
    <script src="https://cdnjs.cloudflare.com/ajax/libs/pdf.js/2.10.377/pdf.min.js"></script>
    <script type="text/javascript" src="//translate.google.com/translate_a/element.js?cb=googleTranslateElementInit"></script>
     <script src="https://cdn.jsdelivr.net/npm/chart.js"></script>
    

    <!-- Metadatos Open Graph -->
    <meta property="og:title" content="YOU TOMORROW">
    <meta property="og:description" content="Ofrecemos un estudio en profundidad de las propiedades genéticas de nuestros participantes.">
    <meta property="og:image" content="https://drive.google.com/file/d/1ZZI3G6Fit_kovvVZolrvchtXQQDrnWYI/view?usp=sharing">
    <meta property="og:url" content="https://ytomorrow.com/">
    <meta property="og:type" content="website">

    <!-- Otros metadatos -->
    <meta name="description" content="Ofrecemos un estudio en profundidad de las propiedades genéticas de nuestros participantes.">
    <meta name="keywords" content="you, YOU TOMORROW, TOMORROW, TOMORR, TOM, web">

    <style>

   body {
    font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif;
    font-size: 17px;
    line-height: 1.4;
    margin: 20px;
    font-weight: 500; /* Grosor medio de la negrita */
    color: #4a4a4a; /* Gris oscuro elegante */
}

h1, h2, h3 {
    color: #4a4a4a; /* Gris oscuro elegante */
}

h1 {
    font-size: 24px;
}

h2 {
    font-size: 20px;
}

h3 {
    font-size: 18px;
}

p {
    margin-bottom: 12px;
    font-size: 18px;
    color: #4a4a4a; /* Gris oscuro elegante */
}

.section {
    margin-bottom: 30px;
    color: #4a4a4a; /* Gris oscuro elegante */
}

.chart-container {
    display: flex;
    flex-direction: column;
    align-items: center;
    font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif;
    color: white;
    width: 100%;
}

.chart-row {
    display: flex;
    justify-content: center;
    margin: 10px 0;
    width: 50%; /* Ajusta el ancho para que se adapte al contenido */
}

.chart-box {
    background: linear-gradient(135deg, #42a5f5, #1e88e5);
    padding: 10px 20px;
    margin: 0 5px;
    border-radius: 12px;
    text-align: center;
    font-size: 18px;
    box-shadow: 0px 4px 6px rgba(0, 0, 0, 0.1);
    display: flex;
    align-items: center;
    justify-content: center;
    transition: transform 0.3s ease;
    position: relative;
    overflow: hidden;
    min-width: 150px; /* Asegura que las tarjetas tengan un ancho mínimo */
    max-width: 300px; /* Limita el ancho máximo para tarjetas largas */
    word-wrap: break-word; /* Permite que el texto se ajuste dentro de la tarjeta */
    flex: 1; /* Permite que las tarjetas se expandan uniformemente */
}

.chart-box:hover {
    transform: scale(1.05);
}

.chart-box.ceo {
    background: linear-gradient(135deg, #ff6f61, #e53935);
    font-weight: bold;
    font-size: 22px;
}

.chart-box::before {
    content: '';
    position: absolute;
    top: -50%;
    left: -50%;
    width: 200%;
    height: 200%;
    background: rgba(255, 255, 255, 0.1);
    opacity: 0;
    transition: opacity 0.3s ease;
    transform: rotate(45deg);
}

.chart-box:hover::before {
    opacity: 1;
}

.chart-box.ceo::before {
    background: rgba(255, 255, 255, 0.2);
}

.connector {
    width: 2px;
    height: 20px;
    background-color: #1b3a7a;
    margin: 0 auto;
}

.horizontal-connector {
    height: 2px;
    width: 100%;
    background-color: #1b3a7a;
}

.horizontal-connector.long {
    width: 50%;
}

.chart-box i {
    margin-right: 8px;
    font-size: 20px;
    color: rgba(255, 255, 255, 0.8);
}


table {
    width: 100%;
    border-collapse: collapse;
    margin-bottom: 20px;
  }
  
  table, th, td {
    border: 1px solid #ddd;
  }

  th, td {
    padding: 12px;
    text-align: center;
  }

  th {
    background-color: #1b5e20;
    color: #1b5e20;
    font-weight: bold;
  }

  tr:nth-child(even) {
    background-color: #f2f2f2;
  }

  tr:hover {
    background-color: #ddd;
  }

  caption {
    caption-side: top;
    font-size: 18px;
    font-weight: bold;
    margin-bottom: 10px;
  }

    </style>

</head>
<body>
<div class="container">
REFERENCES
    <ol>
        
        
        </p>

</div>
<script>
        
    </script>
</body>
</html>